The Evolution of HIV Testing Continues

被引：10
作者：
Delaney, Kevin P. [1 ]
Wesolowski, Laura G. [1 ]
Owen, Sherry Michele [2 ]
机构：
[1] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA
[2] US Ctr Dis Control & Prevent, Off Director, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA USA
来源：
SEXUALLY TRANSMITTED DISEASES | 2017年 / 44卷 / 12期
关键词：
POINT-OF-CARE; LIAT(R) INFLUENZA A/B; VIRAL LOAD; PERFORMANCE EVALUATION; SAMBA I; INFECTION; BLOOD; ASSAY; SEROCONVERSION; SPECIMENS;
D O I：
10.1097/OLQ.0000000000000736
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：747 / 749
页数：3
相关论文
共 35 条
[1]  
[Anonymous], 2016, TECHN UPD HIV 1 2 DI
[2]  
Association of Public Health Laboratories, 2017, SUGG REP LANG HIV LA
[3]   HIV Testing Updates and Challenges: When Regulatory Caution and Public Health Imperatives Collide [J].
Branson, Bernard M. .
CURRENT HIV/AIDS REPORTS, 2015, 12 (01) :117-126
[4]   TIME-COURSE OF DETECTION OF VIRAL AND SEROLOGIC MARKERS PRECEDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION - IMPLICATIONS FOR SCREENING OF BLOOD AND TISSUE DONORS [J].
BUSCH, MP ;
LEE, LLL ;
SATTEN, GA ;
HENRARD, DR ;
FARZADEGAN, H ;
NELSON, KE ;
READ, S ;
DODD, RY ;
PETERSEN, LR .
TRANSFUSION, 1995, 35 (02) :91-97
[5]  
CDC, 2017, TECHN UPD US DET HIV
[6]  
CDC, 2017, HIV LAB TESTS
[7]  
CDC, 2017, ADV DIS FDA APPR HIV
[8]  
CDC, 2017, HIV TEST
[9]  
CDC, 2017, HIV SCREEN STAND CAR
[10]  
CDC, 2017, REQ TRAIN CDCS CAP B
1234